Bernard H. Paul - 14 Jan 2022 Form 3 Insider Report for Acer Therapeutics Inc.

Role
Chief People Officer
Signature
/s/ Harry S. Palmin, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
14 Jan 2022
Net transactions value
$0
Form type
3
Filing time
21 Jan 2022, 15:04:23 UTC
Next filing
16 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACER Employee Stock Option (right to buy) 14 Jan 2022 Common Stock 25,000 $19.35 Direct F1
holding ACER Employee Stock Option (right to buy) 14 Jan 2022 Common Stock 30,000 $3.42 Direct F2
holding ACER Employee Stock Option (right to buy) 14 Jan 2022 Common Stock 10,000 $3.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable over four years as follows: 25% of the shares vest on the one-year anniversary of the grant date, and the remaining 75% of the shares vest quarterly over the remaining three years.
F2 The option vests and becomes exercisable over two years as follows: 50% on 01/01/2021 and 50% on 01/01/2022.

Remarks:

Exhibit List: Exhibit 24 - Confirming Statement